Advisory: FDA recommends modifications to labeling current over-the-counter nicotine replacement therapy products
WINSTON-SALEM, N.C., April 2, 2013 /PRNewswire/ — Niconovum USA has issued the following release: “FDA recommends modifications to labeling current over-the-counter nicotine replacement therapy products.”
Go to Reynolds American Inc.’s website, www.reynoldsamerican.com, to read the full release.
RAI’s website, www.reynoldsamerican.com, is the primary source of publicly disclosed news about RAI and its operating companies. We use the website as our primary means of distributing quarterly earnings and other company news. We encourage investors and others to register at http://www.reynoldsamerican.com/events.cfm to receive alerts when news about the company has been posted.
Niconovum USA, a subsidiary of Reynolds American Inc. (NYSE: RAI), markets Zonnic nicotine gum in Iowa. To learn more about how Reynolds American and its operating companies are transforming the tobacco industry, visit http://TransformingTobacco.com.
SOURCE Niconovum USA, Inc.